|
| Knowledge-related items | |
|
| All ADRs due to a drug are already known when it first comes to the market*. | |
| All ADRs should be reported for newly marketed drugs*. | |
| Serious reactions should be reported for old drugs in use for a long time*. | |
| I do not need to report minor ADR*. | |
| I should report only uncommon ADR*. | |
| I should report ADR only when I am sure that it is due to a drug*. | |
| Who is qualified to report ADRs (medical doctors, nurses, pharmacists, physiotherapist, or multipurpose healthcare workers)&? | |
| What should be monitored for ADRs (vaccines, complementary medicines, over-the-counter drugs, antibiotics, antimalarials, or topical drugs)&? | |
| Purpose of ADR monitoring is (identifying safe drugs, calculating ADR incidence, identifying predisposing factors, identifying previously unrecognized ADRs, and serving as a source of information, for comparison of drugs within the same therapeutic class)&. | |
| Are you aware of the adverse event monitoring system in India#? | |
|
| Attitude-related items | |
|
| I am likely to report an ADR in future*. | |
| ADR reporting improves patient safety*. | |
| I am not doing my job properly unless I report ADR*. | |
| Only one ADR will not make a significant contribution*. | |
| Reporting ADR might create problems for me*. | |
| There should be payment for ADR reporting*. | |
| Reporting ADR will make me responsible for patient harm*. | |
| ADRs are not preventable so there is no point in reporting*. | |
| ADR reporting should be voluntary*. | |
| I am unlikely to report ADRs due to lack of time*. | |
| I do not feel the need to report an ADR that I have recognized*. | |
|
| Demographic characteristics | |
|
| Age, gender, qualification, years of experience in malaria control programme, and training in ADR reporting | |
|
